Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Ask a
question
Favorite
Patients were treated with apatinib at a dosage of 250–750 mg by oral administration once a day, for 4 weeks as a cycle. Whether additional docetaxel was added during the apatinib treatment was determined by multidisciplinary team (MDT) or a senior oncology physician at one of our institutes. The dosage of docetaxel was 75–100 mg/m2 on day 1 every 3 weeks. After failure of treatment, patients were managed according to MDT discretion.
Copyright and License information: ©2019 Lin et al. This work is published and licensed by Dove Medical Press Limited
The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
